CA2066618A1 - Plasmids containing dna encoding the amino acid sequence of tcf-ii, transformed cells with the plasmids, and production method of biologically active substance using the transformed cells - Google Patents

Plasmids containing dna encoding the amino acid sequence of tcf-ii, transformed cells with the plasmids, and production method of biologically active substance using the transformed cells

Info

Publication number
CA2066618A1
CA2066618A1 CA2066618A CA2066618A CA2066618A1 CA 2066618 A1 CA2066618 A1 CA 2066618A1 CA 2066618 A CA2066618 A CA 2066618A CA 2066618 A CA2066618 A CA 2066618A CA 2066618 A1 CA2066618 A1 CA 2066618A1
Authority
CA
Canada
Prior art keywords
transformed cells
plasmids
tcf
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2066618A
Other languages
French (fr)
Other versions
CA2066618C (en
Inventor
Nobuyuki Shima
Kanji Higashio
Masaya Nagoa
Fumiko Oogaki
Hiroaki Takaoka
Eisuke Tsuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2066618A1 publication Critical patent/CA2066618A1/en
Application granted granted Critical
Publication of CA2066618C publication Critical patent/CA2066618C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Plasmids containing DNA encoding the amino acid sequence of a novel glycoprotein (TCF-II) derived from human fibroblasts, transformed cells with the plasmids and production method of rTCF-II using the transformed cells. rTCF-II can be used as a hepatocyte growth factor or a tumor cytotoxic factor.
CA002066618A 1990-07-13 1991-07-15 Plasmids containing dna encoding the amino acid sequence of tcf-ii, transformed cells with the plasmids, and production method of biologically active substance using the transformed cells Expired - Fee Related CA2066618C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18585290 1990-07-13
JP185852/1990 1990-07-13

Publications (2)

Publication Number Publication Date
CA2066618A1 true CA2066618A1 (en) 1992-01-14
CA2066618C CA2066618C (en) 1998-05-19

Family

ID=16178009

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002066618A Expired - Fee Related CA2066618C (en) 1990-07-13 1991-07-15 Plasmids containing dna encoding the amino acid sequence of tcf-ii, transformed cells with the plasmids, and production method of biologically active substance using the transformed cells

Country Status (10)

Country Link
US (1) US5328836A (en)
EP (1) EP0539590B1 (en)
JP (1) JP2634323B2 (en)
KR (1) KR0153009B1 (en)
AT (1) ATE178354T1 (en)
CA (1) CA2066618C (en)
DE (1) DE69131069T2 (en)
DK (1) DK0539590T3 (en)
ES (1) ES2132087T3 (en)
WO (1) WO1992001053A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
US5821223A (en) * 1990-09-14 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen
JP3395181B2 (en) * 1991-07-26 2003-04-07 東レ株式会社 Hematopoietic stem cell augmentation agent
CA2118012A1 (en) * 1992-05-18 1993-11-25 Paul J. Godowski Hepatocyte growth factor variants
US5328837A (en) * 1992-05-18 1994-07-12 Genentech, Inc. Hepatocyte growth factor protease domain variants
US5316921A (en) * 1992-05-18 1994-05-31 Genentech, Inc. Single-chain hepatocyte growth factor variants
DK0821969T3 (en) * 1992-07-16 2007-03-26 Daiichi Seiyaku Co Medical composition comprising TCF-II
CA2140010C (en) * 1992-07-16 2008-04-01 Hiroaki Masunaga Blood coagulation normalizer containing tcf-ii as active ingredient
JP3402476B2 (en) * 1992-08-24 2003-05-06 生化学工業株式会社 Lipopolysaccharide binding protein and method for producing the same
JP3552240B2 (en) * 1993-02-23 2004-08-11 第一製薬株式会社 High concentration TCF preparation
IT1271088B (en) * 1994-11-24 1997-05-26 Dompe Spa USE OF HEPATOCYTE GROWTH FACTOR TO INDUCE THE PROLIFERATION AND DIFFERENTIATION OF HEMATOPOIETIC CELLS
EP0757994B1 (en) * 1994-12-27 2003-09-03 Daiichi Pharmaceutical Co., Ltd. Tcf mutant
KR19980020025A (en) * 1996-09-05 1998-06-25 김종진 Removal of Naphthalene in Wastewater Using Microorganisms
JP4006058B2 (en) 1997-03-11 2007-11-14 第一三共株式会社 Agent for preventing and / or treating multiple organ failure
DK0950416T3 (en) * 1997-03-14 2007-02-26 Daiichi Seiyaku Co Use of TCF-II to treat cancer-related loss of body weight, anemia and TNF elevation
KR100562824B1 (en) 2002-03-20 2006-03-23 주식회사 바이로메드 Hybrid hepatocyte growth factor gene that expresses two genes of hepatocyte growth factor with high gene expression efficiency
EP1814575A4 (en) * 2004-11-24 2010-07-07 Neopro Labs Llc METHODS AND COMPOSITIONS FOR TREATING DISORDERS
CA2647835A1 (en) * 2006-03-28 2007-10-04 Neopro Labs, Llc Methods and compositions for treating conditions
EP2152725A1 (en) 2007-05-17 2010-02-17 Neopro Labs, LLC Crystalline and amorphous forms of peptide
WO2009012472A2 (en) * 2007-07-18 2009-01-22 Neopro Labs, Llc Methods and compositions for treating conditions
US20090202606A1 (en) * 2008-01-25 2009-08-13 Viromed Co., Ltd. Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor
BRPI0911511B8 (en) * 2008-04-09 2021-05-25 Helixmith Co Ltd lyophilized DNA formulation to increase plasmid DNA expression
CA2926607C (en) 2013-10-22 2018-10-23 Viromed Co., Ltd. Composition for preventing or treating amyotrophic lateral sclerosis using two or more isoforms of hepatocyte growth factor
EP3823677A4 (en) 2018-07-19 2022-06-01 Helixmith Co., Ltd. FREEZE-DRIED PHARMACEUTICAL COMPOSITIONS INTENDED FOR NAKED-DNA GENE THERAPY

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62171696A (en) * 1986-01-23 1987-07-28 Sumitomo Chem Co Ltd Production of human erythropoietin
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
CA2022752C (en) * 1989-08-11 1998-07-07 Naomi Kitamura Hepatic parenchymal cell growth factor, gene encoding the same, process for producing the factor, and transformants producing the factor
JP2777678B2 (en) * 1990-06-11 1998-07-23 敏一 中村 Recombinant human hepatocyte growth factor and method for producing the same

Also Published As

Publication number Publication date
DK0539590T3 (en) 1999-10-11
US5328836A (en) 1994-07-12
ATE178354T1 (en) 1999-04-15
KR920702417A (en) 1992-09-04
DE69131069T2 (en) 1999-07-15
DE69131069D1 (en) 1999-05-06
CA2066618C (en) 1998-05-19
JP2634323B2 (en) 1997-07-23
EP0539590A4 (en) 1995-05-24
KR0153009B1 (en) 1998-10-15
EP0539590A1 (en) 1993-05-05
EP0539590B1 (en) 1999-03-31
WO1992001053A1 (en) 1992-01-23
ES2132087T3 (en) 1999-08-16

Similar Documents

Publication Publication Date Title
CA2066618A1 (en) Plasmids containing dna encoding the amino acid sequence of tcf-ii, transformed cells with the plasmids, and production method of biologically active substance using the transformed cells
CA2267651A1 (en) Method of stimulating growth of melanocyte precursor cells with stem cell factor polypeptide
AU580076B2 (en) Dental preparation, article and method for storage and delivery thereof
ZA907338B (en) Thienylcarboxylates of amino alcohols
ATE149524T1 (en) DNA ENCODING A HUMAN VASOCONTRACTING PEPTIDE AND ITS USE
EP0158277A3 (en) Implantable controlled-release preparations of regulatory peptides, and process for their preparation
LTIP1652A (en) Protein, biologically active hormone, method for protein production, pharmaceutical preparation
GR3021106T3 (en) Production of bacteria and yeast of hemoglobin and analogues thereof
EP0187991A3 (en) Antitumor active substance, process for preparing the same, drug containing the substance, gene coding for the substance, vector containing the gene and recombinant microorganism
CA2147623A1 (en) Novel p-selectin ligand protein
AU1562988A (en) DNA clone of human thrombomodulin
DE3681144D1 (en) USE OF BIOLOGICALLY ACTIVE COPOLYMERS FOR THE PRODUCTION OF A MEDICINAL PRODUCT FOR STIMULATING THE GROWTH OF ANIMALS.
AU637139B2 (en) Gm-csf protein, its derivatives, the preparation of proteins of this type, and their use
ATE111521T1 (en) POLYPEPTIDE AND ITS PRODUCTION.
JPS6426567A (en) Pyrazine compound, manufacture and plant growth regulant composition
AU1987088A (en) A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
CA2011008A1 (en) Egf variants and pharmaceutical use thereof
GB8819826D0 (en) Glycosylated igf-1
EP0315118A3 (en) Dna coding for endothelin and use thereof
AU5484386A (en) Expression in E. coli of hybrid polypeptides containing the growth hormone releasing factor sequence
AU7265087A (en) Animal cell transformant, method for obtaining the transformant and method for producing desired foreign gene product by using the transformant
CA2080008A1 (en) Water-soluble mutein of fibroblast growth factor (fgf) receptor
HUT37892A (en) Process for stabilizing physiologically active material prepared by recombinat dna technique, and for preparing aqueous solution or powder containing this material
AU7880987A (en) Human B-cell differentiation factor and process of producing said factor
CA2089111A1 (en) Smooth muscle mitogen and isolated dna coding therefor

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed